Search clinical trials for: Docetaxel, Anthracycline (Doxorubicin or Epirubicin), Cyclophosphamide
Total 257 results
-
Beth Israel Deaconess Medical CenterActive, not recruiting
-
NSABP Foundation IncNational Cancer Institute (NCI)Active, not recruitingBreast CancerUnited States, Puerto Rico
-
Washington University School of MedicineNovartis; PfizerCompletedBreast NeoplasmsUnited States
-
SanofiCancer International Research Group (CIRG)CompletedBreast NeoplasmsUnited States, France, Brazil, Romania, Russian Federation, Australia, Spain, Sweden, Turkey, India, Slovakia, Taiwan, Belgium, Czech Republic, Tunisia, Uruguay, Argentina, Croatia, Austria, Egypt, Greece, Hungary, Ireland, Israel, Italy, Mexic... and more
-
Merck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast NeoplasmsBrazil, Canada, United States, United Kingdom, Taiwan, Australia, Colombia, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Poland, Portugal, Russian Federation, Singapore, Spain, Sweden, Turkey
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerRecurrent Breast Carcinoma | HER2/Neu Positive | Progesterone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Canada, Puerto Rico, Ireland
-
GlaxoSmithKlineTerminatedNeoplasms, BreastUnited States, Belgium, United Kingdom, Germany, Russian Federation, Italy, France
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
NSABP Foundation IncGenentech, Inc.; International Drug Development InstituteCompleted
-
German Breast GroupAstraZenecaCompletedBreast Cancer | Triple Negative Breast Neoplasms | HRpos Breast Neoplasms | BRCA 1 /2 and / or HRDGermany
-
AstraZenecaDaiichi SankyoRecruitingBreast CancerChina, United States, Italy, Spain, United Kingdom, Korea, Republic of, Canada, Germany, Poland, Belgium, Japan, Vietnam, Bulgaria, France, Brazil, India, Malaysia, Taiwan, Thailand, Hungary, Australia, Austria, Turkey, Hong Kong, Switz... and more
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Priyanka SharmaCompletedTriple-negative Breast CancerUnited States
-
University of Kansas Medical CenterRecruitingBreast Cancer | Triple Negative Breast CancerUnited States
-
University of ArkansasCompleted
-
Spanish Breast Cancer Research GroupSanofiCompleted
-
SanofiCancer International Research Group (CIRG)CompletedBreast CancerUnited States, France, Canada, Brazil, Poland, Germany, Portugal, Spain, Sweden, Slovakia, Czech Republic, Uruguay, Argentina, Egypt, Hungary, Israel, South Africa, Austria, Greece, United Kingdom
-
Hoffmann-La RocheCompleted
-
Fudan UniversityNot yet recruitingNeoadjuvant Therapy | Early Breast Cancer | HR+HER2- Breast Cancer
-
Icahn School of Medicine at Mount SinaiTerminatedLocally Advanced Breast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerTurkey, Algeria, Morocco, Saudi Arabia, Tunisia
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B Cell Lymphoma (DLBCL) | Elderly Patients (>65 Years)Italy
-
NSABP Foundation IncHoffmann-La Roche; Genentech, Inc.; Cancer International Research Group (CIRG)TerminatedBreast CancerKorea, Republic of, United States, Canada, Spain, Ireland, Australia, Argentina, China, United Kingdom, Germany, Brazil, Hong Kong, France, Israel, Taiwan, Serbia, Belgium, Thailand, Croatia, Egypt, Italy, Philippines, Bosnia and Herzegovina and more
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompleted
-
Spanish Breast Cancer Research GroupPfizerCompleted
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Early Stage Triple-Negative Breast CarcinomaUnited States, Puerto Rico
-
West German Study GroupAGO GermanyCompletedBreast CancerGermany
-
Novartis PharmaceuticalsRecruitingFollicular Lymphoma (FL)Australia, Korea, Republic of, Spain, Singapore, Poland, Taiwan, Hungary, Czechia, Romania, Slovakia
-
NSABP Foundation IncHoffmann-La Roche; Genentech, Inc.; International Drug Development InstituteCompleted
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompleted
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Renske AltenaTerminatedHER2-positive Breast Cancer | Early-stage Breast CancerSweden
-
M.D. Anderson Cancer CenterWithdrawnBreast Cancer
-
NSABP Foundation IncNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
NSABP Foundation IncNational Cancer Institute (NCI)CompletedBreast CancerUnited States, Canada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
National Institute of Oncology, HungaryNot yet recruiting
-
Albert Einstein College of MedicineMerck Sharp & Dohme LLCCompletedBreast CancerUnited States
-
ImmunityBio, Inc.Withdrawn
-
National Cancer Center, KoreaRecruitingBreast Cancer | Invasive Breast CancerKorea, Republic of
-
SanofiCompleted
-
St. Jude Children's Research HospitalActive, not recruitingRetinoblastomaUnited States
-
Karolinska University HospitalRecruiting
-
Hoffmann-La RocheCompletedHER2-Positive Metastatic Breast Cancer | HER2-Negative Metastatic Breast Cancer | Locally Advanced or Early Breast CancerUnited States
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedLymphomaUnited States, Australia, France, Poland, United Kingdom, China, Belgium, Germany, Spain, Israel, Turkey, Ukraine, Japan, Taiwan, Canada, Denmark, Finland, Korea, Republic of, Netherlands, Brazil, Russian Federation, Argentina, Norway, Swed... and more
-
GlaxoSmithKlineCompletedLymphoma, FollicularUnited States
-
Xijing HospitalUnknown
-
Hoffmann-La RocheActive, not recruiting
-
Spanish Breast Cancer Research GroupEli Lilly and CompanyActive, not recruiting